Cardinal Health, Inc. $CAH Shares Purchased by Lombard Odier Asset Management Switzerland SA

Lombard Odier Asset Management Switzerland SA lifted its holdings in Cardinal Health, Inc. (NYSE:CAH) by 40.9% in the 1st quarter, Holdings Channel.com reports. The firm owned 26,714 shares of the company’s stock after purchasing an additional 7,761 shares during the quarter. Lombard Odier Asset Management Switzerland SA’s holdings in Cardinal Health were worth $5,645,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of CAH. University of Texas Texas AM Investment Management Co. acquired a new stake in Cardinal Health in the fourth quarter valued at approximately $26,000. Bank of Jackson Hole Trust purchased a new stake in shares of Cardinal Health in the fourth quarter valued at approximately $27,000. Jones Financial Companies Lllp raised its stake in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the period. Palladiem LLC purchased a new position in shares of Cardinal Health during the 4th quarter valued at approximately $28,000. Finally, Indiana Trust & Investment Management Co purchased a new position in shares of Cardinal Health during the 1st quarter valued at approximately $29,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

NYSE CAH opened at $227.96 on Friday. The business has a fifty day moving average price of $219.98 and a 200 day moving average price of $214.43. The company has a market cap of $53.39 billion, a P/E ratio of 34.86, a P/E/G ratio of 1.12 and a beta of 0.49. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $243.21.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 10.77 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were paid a dividend of $0.5158 per share. The ex-dividend date of this dividend was Wednesday, July 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is currently 31.50%.

Wall Street Analyst Weigh In

CAH has been the subject of several recent analyst reports. Bank of America boosted their price target on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, July 2nd. William Blair started coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They set an “outperform” rating on the stock. Mizuho boosted their target price on shares of Cardinal Health from $235.00 to $240.00 and gave the stock an “outperform” rating in a research note on Thursday. Morgan Stanley boosted their target price on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. Finally, Citigroup upped their price target on shares of Cardinal Health from $245.00 to $265.00 and gave the stock a “buy” rating in a research report on Friday. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $251.73.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.